Abstract
The effect of preadministration of bismuth, a specific potent inducer of renal metallothionein (MT), on the lethal and renal toxicity of cis-DDP, an extensively used antitumor drug containing heavy metal platinum, in mice was investigated. Pretreatment of mice with two s.c. doses of bismuth nitrate (BN; 30μmol/kg/day) at 24-hr interval prevented the lethal toxicity, the increase in BUN value and the occurrence of diarrhea caused by cis-DDP (35μmol/kg, s.c.). This protective effect of BN-pretreatment was signifincantly correlated with increased MT levels in the kidney. The pretreatment of tumor-bearing mice with BN also depressed the lethal and renal toxicity of cis-DDP without compromising its antitumor activity, and allowed the administration of relatively high dose of cis-DDP. Daily five consecutive p.o. preadministration of bismuth subnitrate (BSN), one of the bismuth compounds being in use as a protectant of the gastrointestinal lining, was also effective to depress the lethal toxicity of cis-DDP. Since the effective dose of BSN is not far from that commonly used for men, this treatment will allow the increase in cis-DDP dose, promising a clinical advantage in cancer chemotherapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rosenberg, B. (1969) Nature 222, 385–386.
Einhorn, L.H. and Donohue, J.P. (1977) Ann. Int. Med. 87, 293–298.
Von Hoff, D.D., Schilsky, R., Reichert, C.M., Reddick, R.L., Rozencweig, M, Young, R.C. and Muggia, F.M. (1977) Cancer Treap. Rep. 61, 375–379.
Madias, N.E. and Harrington, J.T. (1978) 65, 307–314.
Yoshikawa, H. (1974) Ind. Health 12, 175–177.
Webb, M. (1972) Biochem. Pharmacol. 21, 2767–2771.
Yamane, Y., Fukino, H. and Imagawa, M. (1977) 25, 1509–1518.
Leber, P.A. and Miya, T.S. (1976) Toxicol. Appl. Pharmacol. 37, 403–414.
Mason, R., Edwards, I.R. and Mclaren, S.J. (1984) Chem.-Biol. Interact. 49, 165–176.
Sharma, R.P., and Edwards, I.R. (1983) Biochem. Pharmacol. 32, 2665–2669.
Zelazowski, A.J., Garvey, J.S. and Hoeschele, J.D. (1984) Arch. Biochem. Biophys. 229, 246–252.
Bakka, A.B., Endresen, L., Johnsen, A.B.S., Edminson, P.D. and Rugstad, H.E. (1981) Toxicol. Appl. Pharmacol. 61, 215–226.
Piotrowski, J.K., Bolanowka, W. and Sapata, A. (1973) Acta Biochem. Polon. 20, 207–215.
Kotsonis, F.N. and Klassen, C.D. (1977) Toxicol. Appl. Pharmacol. 42, 583–588.
Koyama, Y., Nakatogawa, K., Naganuma, A. and Imura, N., Onosaka, S. and Tanaka, K. (1984) Jap. J. Hyg. 39, 385.
Szymanska, J.A., Mogilnicka, E.M. and Kaszper, B.W. (1977) Biochem. Pharmacol. 26, 257–258.
Piotrowski, J.K., Szymanska, J.A., Mogilnicka, E.M. and Zelazowski, A.J. (1979) Experientia, Suppl. 34, 363–371.
Endresen, L., Schjierven, L. and Rugstad, H.E. (1984) Acta Pharmacol. Toxicol. 55, 183–187.
Naganuma, A., Satoh, M., Koyama, Y. and Imura, N. (1985) Toxicol. Lett. 24, 203–207.
Naganuma, A., Satoh, M. and Imura, N. (1984) Res. Commun. Chem. Pathol. Pharmacol. 46, 265–270.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Basel AG
About this chapter
Cite this chapter
Imura, N., Naganuma, A., Satoh, M., Hoyaaa, Y. (1987). Induction of Renal Metallothionein Allows Increasing Dose of an Extensively Used Antitumor Drug, cis-Diamminedichloroplatinum. In: Kägi, J.H.R., Kojima, Y. (eds) Metallothionein II. Experientia Supplementum, vol 52. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-6784-9_70
Download citation
DOI: https://doi.org/10.1007/978-3-0348-6784-9_70
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-6786-3
Online ISBN: 978-3-0348-6784-9
eBook Packages: Springer Book Archive